Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 5, 2009, Pages 544-549

  Bakar, Ö ^a   Demircay, Z ^b   Toker, E ^b   Cakir S ^c  

^a Acibadem Kozyatagi Hospital   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c NONE

Author keywords

Ocular; Papulopustular rosacea; Treatment

Indexed keywords

AZITHROMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; ROSACEA; SCORING SYSTEM;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; EYE; FEMALE; HUMANS; MALE; MIDDLE AGED; ROSACEA; TEARS;

EID: 63849191011     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03132.x     Document Type: Article

References (32)

1. Crawford GH, Pelle MT, James WD, Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004 51 : 327 341.
2. Michel JL, Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. Ann Dermatol Venereol 2003 130 : 20 24.
3. Starr PAJ, McDonald A. Oculo-cutaneous aspects of rosacea. Proc R Soc Med 1969 62 : 9 11.
4. Wilkin JK, Dahl M, Detmar M et al. Standard classification of rosacea. Report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 2002 46 : 584 587.
5. Ghanem VC, Mehra N, Wong S et al. The prevelance of ocular signs in acne rosacea. Cornea 2003 22 : 230 233.
6. Jenkins MS, Brown SI, Lempert SL et al. Ocular rosacea. Am J Ophthalmol 1979 88 : 618 622.
7. Akpek ES, Merchant A, Pinar V et al. Ocular rosacea: patient characteristics and follow-up. Ophthalmology 1997 104 : 1863 1867.
8. Tanzi EL, Weinberg JM. The ocular manifestations of rosacea. Cutis 2001 68 : 112 114.
9. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy J Am Acad Dermatol 2004 51 : 499 512.
10. Stone DU, Codosh J. Oral tetracyclines for ocular rosacea: an evidence-based review of the literature. Cornea 2004 23 : 106 109.
11. Quarterman MJ, Johnson DW, Abele DC et al. Ocular rosacea. Signs symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol 1997 133 : 49 54.
12. Frucht-Pery J, Sagi E, Hemo I et al. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 1993 116 : 88 92.
13. Paranjpe DR, Foulks GN. Therapy for meibomian gland disease. Ophthalmol Clin North Am 2003 16 : 37 42.
14. Tsankov N, Broshtilova V, Kazandjieva J. Tetracyclines in dermatology. Clin Dermatol 2003 21 : 33 39.
15. Bakar Ö, Demircay Z, Gurbuz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol 2004 43 : 151 154.
16. Key JE. A comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J 1996 22 : 209 212.
17. Stone DU, Codosh J. Ocular rosacea. an update on pathogenesis and therapy. Curr Opin Ophthalmol 2004 15 : 499 502.
18. Greiner JV, Leahy CD, Glonek T et al. Effects of eyelid scrubbing on the lid margin. CLAO J 1999 25 : 109 113.
19. Bakar Ö, Demircay Z, Yuksel M, Haklar G, Sanisolu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 2007 32 : 197 200.
20. Fernandez-Obregon A. Azithromycin for the treatment of acne. Int J Dermatol 2000 39 : 45 50.
21. Rubin BK. Immunomodulatory properties of macrolides: overview and historical perspective. Am J Med 2004 117 (Suppl. 9 2S 4S.
22. Barton K, Monroy DC, Nava A et al. Inflammatory cytokins in the tears of patients with ocular rosacea. Ophthalmology 1997 104 : 1868 1874.
23. Afonso AA, Sobrin L, Monroy DC et al. Tear fluid gelatinase B activity correlates with IL-1α concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999 40 : 2506 2512.
24. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med 2004 117 (9 Suppl. 1 5S 11S.
25. Tamaoki J. The effects of macrolides on inflammatory cells. Chest 2004 125 (Suppl. 2 415 505.
26. Tabbara KF, al-Kharashi SA, al-Mansouri SM et al. Ocular levels of azithromycin. Arch Ophthalmol 1998 116 : 1625 1628.
27. Hoang-Xuan T, Rodriguez A, Zaltas MM, Rice BA, Foster CS. Ocular rosacea. A histologic and immunopathologic study. Ophthalmology 1990 97 : 1468 1475.
28. Yaylali V, Ozyurt C. Comparison of tear function tests and impression cytology with the ocular findings in acne rosacea. Eur J Ophthalmol 2002 12 : 11 17.
29. Afonso AA, Monroy D, Stern ME et al. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology 1999 4 : 803 810.
30. Macri A, Pflugfelder S. Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol 2000 118 : 1632 1638.
31. Koçak-Altyntaş AG, Koçak-Midillioglu I, Gül U et al. Impression cytology and ocular characteristics in ocular rosacea. Eur J Ophthalmol 2003 13 : 351 359.
32. Chiambaretta F, Garraffo R, Elena PP, Pouliquen P et al. Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers. Eur J Ophthalmol 2008 18 : 13 20.